It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Following the generation of the first fully human recombinant antibodies derived from COVID-19 patients, Active Motif has continued to pioneer the development of novel reagents to study SARS-CoV-2.
Active Motif’s new SARS-CoV-2 Spike S1 Protein ELISA Kit is designed to detect the Spike S1 protein receptor-binding domain (RBD) from biological samples such as saliva, plasma, or cell culture supernatant.
This complete ELISA Kit contains an optimized protocol and all necessary reagents to perform the assay on a single pre-coated 96-well plate. Recombinant Spike S1 protein provided in the kit can be used to generate a standard curve for quantification of Spike S1 protein levels in your sample of interest.
originally posted by: tamusan
a reply to: rickymouse
The kit contains sufficient reagents to perform 96 reactions.
originally posted by: Nivhk
Everything coming out makes it seem less like they are testing for "covid" and looking to gather information.
We're to believe a safe vaccine has been released to the public when they can't even agree with a single procedure to test for covid?
originally posted by: Nivhk
a reply to: chr0naut
From you, yourself.
Reliable.
Again, we're suppose to believe a flawless vaccine is available for consumption when we don't even have reliable testing?
Come on, we both know someone's lying for the bottom line.
And we both know it isn't people actually sick. Just another pyramid scheme by big brother pharma.